Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
AbbVie
Diakonhjemmet Hospital
Virtual Tribunal Monastery
University of Pittsburgh
Zimmer Biomet
Bristol-Myers Squibb
Bristol-Myers Squibb
Brigham and Women's Hospital
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
ProgenaBiome
Universitätsklinikum Hamburg-Eppendorf
Pfizer
Instituto Mexicano del Seguro Social
University of California, San Diego
University of California, San Diego
Exactech
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
VitaMed Research LLC
RemeGen Co., Ltd.
Mabscale, LLC
UCB Pharma
Aalborg University Hospital
Pfizer
Georgetown University
Brigham and Women's Hospital
Rigshospitalet, Denmark
Global Healthy Living Foundation
King's College London
R-Pharm
Atara Biotherapeutics
St George's, University of London
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Alliance Foundation Trials, LLC.
Ionis Pharmaceuticals, Inc.
Peking University Third Hospital
Peking Union Medical College Hospital
Sohag University
Brigham and Women's Hospital
Bristol-Myers Squibb
University of Sulaimani
Sanofi
Bristol-Myers Squibb
National Institute of Allergy and Infectious Diseases (NIAID)
AbbVie
Pfizer
Universidade Nova de Lisboa
UCB Pharma